-
1
-
-
0037673945
-
Osteoclast differentiation and activation
-
Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003; 423: 337-342.
-
(2003)
Nature
, vol.423
, pp. 337-342
-
-
Boyle, W.J.1
Simonet, W.S.2
Lacey, D.L.3
-
2
-
-
0037135169
-
Women's health. The vanishing promises of hormone replacement
-
Enserink M. Women's health. The vanishing promises of hormone replacement. Science 2002; 297: 325-326.
-
(2002)
Science
, vol.297
, pp. 325-326
-
-
Enserink, M.1
-
3
-
-
0038013575
-
Sex steroids and bone: Current perspectives
-
Balasch J. Sex steroids and bone: current perspectives. Hum Reprod Update 2003; 9: 207-22.
-
(2003)
Hum Reprod Update
, vol.9
, pp. 207-222
-
-
Balasch, J.1
-
4
-
-
78049445662
-
Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series
-
Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, et al. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 2010; 123: 1060-1064.
-
(2010)
Am J Med
, vol.123
, pp. 1060-1064
-
-
Fedele, S.1
Porter, S.R.2
D'aiuto, F.3
Aljohani, S.4
Vescovi, P.5
Manfredi, M.6
-
5
-
-
0035018612
-
Perspective: Nonreproductive sites of action of reproductive hormones
-
Manolagas SC, Kousteni S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology 2001; 142: 2200-2204.
-
(2001)
Endocrinology
, vol.142
, pp. 2200-2204
-
-
Manolagas, S.C.1
Kousteni, S.2
-
6
-
-
0034504525
-
Estrogen, bone, growth and sex: A sea change in conventional wisdom
-
Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000; 13 Suppl 6: 1439-1455.
-
(2000)
J Pediatr Endocrinol Metab
, vol.13
, Issue.SUPPL. 6
, pp. 1439-1455
-
-
Grumbach, M.M.1
-
7
-
-
0000031765
-
Gender-independent induction of murine osteoclast apoptosis in vitro by either estrogens or non-aromatizable androgens
-
Chen JR, Kousteni S, Bellido T, Han L, DiGregorio GB, Jilka RL, et al. Gender-independent induction of murine osteoclast apoptosis in vitro by either estrogens or non-aromatizable androgens. J Bone Miner Res 2001; 16 (Suppl 1): S159.
-
(2001)
J Bone Miner Res
, vol.16
, Issue.SUPPL. 1
-
-
Chen, J.R.1
Kousteni, S.2
Bellido, T.3
Han, L.4
Digregorio, G.B.5
Jilka, R.L.6
-
8
-
-
0037211772
-
Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines
-
Yoshida S, Honda A, Matsuzaki Y, Fukushima S, Tanaka N, Takagiwa A, et al. Anti-proliferative action of endogenous dehydroepiandrosterone metabolites on human cancer cell lines. Steroids 2003; 68: 73-83.
-
(2003)
Steroids
, vol.68
, pp. 73-83
-
-
Yoshida, S.1
Honda, A.2
Matsuzaki, Y.3
Fukushima, S.4
Tanaka, N.5
Takagiwa, A.6
-
9
-
-
0031865832
-
Dehydroepiandrosterone (DHEA) sulfate prevents reduction in tissue vitamin E and increased lipid peroxidation due to murine retrovirus infection of aged mice
-
Araghi-Niknam M, Ardestani SK, Molitor M, Inserra P, Eskelson CD, Watson RR. Dehydroepiandrosterone (DHEA) sulfate prevents reduction in tissue vitamin E and increased lipid peroxidation due to murine retrovirus infection of aged mice. Proc Soc Exp Biol Med 1998; 218: 210-217.
-
(1998)
Proc Soc Exp Biol Med
, vol.218
, pp. 210-217
-
-
Araghi-Niknam, M.1
Ardestani, S.K.2
Molitor, M.3
Inserra, P.4
Eskelson, C.D.5
Watson, R.R.6
-
11
-
-
57049102852
-
Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice
-
Wang L, Wang YD, Wang WJ, Li DJ. Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice. Osteoporos Int 2009; 20: 79-92.
-
(2009)
Osteoporos Int
, vol.20
, pp. 79-92
-
-
Wang, L.1
Wang, Y.D.2
Wang, W.J.3
Li, D.J.4
-
12
-
-
34248139066
-
Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor
-
Wang L, Wang YD, Wang WJ, Zhu Y, Li DJ. Dehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptor. J Mol Endocrinol 2007; 38: 467-479.
-
(2007)
J Mol Endocrinol
, vol.38
, pp. 467-479
-
-
Wang, L.1
Wang, Y.D.2
Wang, W.J.3
Zhu, Y.4
Li, D.J.5
-
13
-
-
0032544518
-
Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast
-
Akatsu T, Murakami T, Nishikawa M, Ono K, Shinomiya N, Tsuda E, et al. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 1998; 250: 229-234.
-
(1998)
Biochem Biophys Res Commun
, vol.250
, pp. 229-234
-
-
Akatsu, T.1
Murakami, T.2
Nishikawa, M.3
Ono, K.4
Shinomiya, N.5
Tsuda, E.6
-
14
-
-
0037204816
-
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
-
Kim YH, Kim GS, Jeong-Hwa B. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med 2002; 34: 145-151.
-
(2002)
Exp Mol Med
, vol.34
, pp. 145-151
-
-
Kim, Y.H.1
Kim, G.S.2
Jeong-Hwa, B.3
-
15
-
-
17144438059
-
Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover
-
Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, et al. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 2000; 105: 935-943.
-
(2000)
J Clin Invest
, vol.105
, pp. 935-943
-
-
Ogata, N.1
Chikazu, D.2
Kubota, N.3
Terauchi, Y.4
Tobe, K.5
Azuma, Y.6
-
16
-
-
0035831020
-
Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
-
Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001; 104:719-730.
-
(2001)
Cell
, vol.104
, pp. 719-730
-
-
Kousteni, S.1
Bellido, T.2
Plotkin, L.I.3
O'Brien, C.A.4
Bodenner, D.L.5
Han, L.6
-
17
-
-
0037673933
-
Control of osteoblast function and regulation of bone mass
-
Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003; 423: 349.
-
(2003)
Nature
, vol.423
, pp. 349
-
-
Harada, S.1
Rodan, G.A.2
-
18
-
-
0034284970
-
Bone resorption by osteoclasts
-
Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-1508.
-
(2000)
Science
, vol.289
, pp. 1504-1508
-
-
Teitelbaum, S.L.1
-
19
-
-
0037129205
-
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta
-
Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002; 416: 744-749.
-
(2002)
Nature
, vol.416
, pp. 744-749
-
-
Takayanagi, H.1
Kim, S.2
Matsuo, K.3
Suzuki, H.4
Suzuki, T.5
Sato, K.6
-
20
-
-
7344233085
-
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
-
Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, et al. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 1998; 273: 14363-14367.
-
(1998)
J Biol Chem
, vol.273
, pp. 14363-14367
-
-
Emery, J.G.1
McDonnell, P.2
Burke, M.B.3
Deen, K.C.4
Lyn, S.5
Silverman, C.6
-
21
-
-
0037129387
-
Medicine: Interfering with bone remodelling
-
Alliston T, Derynck R. Medicine: interfering with bone remodelling. Nature 2002; 416: 686-687.
-
(2002)
Nature
, vol.416
, pp. 686-687
-
-
Alliston, T.1
Derynck, R.2
-
22
-
-
0032584208
-
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
-
Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998; 95: 3597-3602.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 3597-3602
-
-
Yasuda, H.1
Shima, N.2
Nakagawa, N.3
Yamaguchi, K.4
Kinosaki, M.5
Mochizuki, S.6
-
23
-
-
79960050582
-
Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation
-
Yang L, Hai Y, Zhou JL. Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. Chin Med J 2011; 124: 2033-2037
-
(2011)
Chin Med J
, vol.124
, pp. 2033-2037
-
-
Yang, L.1
Hai, Y.2
Zhou, J.L.3
-
24
-
-
0032577903
-
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
-
Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 1998; 247: 610-615.
-
(1998)
Biochem Biophys Res Commun
, vol.247
, pp. 610-615
-
-
Mizuno, A.1
Amizuka, N.2
Irie, K.3
Murakami, A.4
Fujise, N.5
Kanno, T.6
-
25
-
-
84859994210
-
Experimental study of Dehydroepiandrosterone for inhibiting osteoblastic apoptosis
-
Wang YD, Luo LM, Tong JQ, Li DJ. Experimental study of Dehydroepiandrosterone for inhibiting osteoblastic apoptosis. Chin J Obst Gyn (Chin) 2005; 40: 844-845.
-
(2005)
Chin J Obst Gyn (Chin)
, vol.40
, pp. 844-845
-
-
Wang, Y.D.1
Luo, L.M.2
Tong, J.Q.3
Li, D.J.4
-
26
-
-
78149284767
-
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
-
Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, et al. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010; 468: 103-107.
-
(2010)
Nature
, vol.468
, pp. 103-107
-
-
Gonzalez-Suarez, E.1
Jacob, A.P.2
Jones, J.3
Miller, R.4
Roudier-Meyer, M.P.5
Erwert, R.6
-
27
-
-
78149284013
-
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer
-
Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010; 468: 98-102.
-
(2010)
Nature
, vol.468
, pp. 98-102
-
-
Schramek, D.1
Leibbrandt, A.2
Sigl, V.3
Kenner, L.4
Pospisilik, J.A.5
Lee, H.J.6
-
28
-
-
0036013436
-
ERbeta has nongenomic action in caveolae
-
Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERbeta has nongenomic action in caveolae. Mol Endocrinol 2002; 16: 938-946.
-
(2002)
Mol Endocrinol
, vol.16
, pp. 938-946
-
-
Chambliss, K.L.1
Yuhanna, I.S.2
Anderson, R.G.3
Mendelsohn, M.E.4
Shaul, P.W.5
-
30
-
-
33645292945
-
Activation of p38 mitogen-activated protein kinase contribute to BMP4-induced alkaline phosphatase expression in MC3T3-E1 preosteoblast
-
Yuan Y, Wu ZJ, Yao HY, Yu XD, Guo ZK, Chen XS, et al. Activation of p38 mitogen-activated protein kinase contribute to BMP4-induced alkaline phosphatase expression in MC3T3-E1 preosteoblast. Chin Med J 2006; 119: 324-327.
-
(2006)
Chin Med J
, vol.119
, pp. 324-327
-
-
Yuan, Y.1
Wu, Z.J.2
Yao, H.Y.3
Yu, X.D.4
Guo, Z.K.5
Chen, X.S.6
-
31
-
-
42349100414
-
Akt1 in osteoblasts and osteoclasts controls bone remodeling
-
Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, Saito T, et al. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One 2007; 2: e1058.
-
(2007)
PLoS One
, vol.2
-
-
Kawamura, N.1
Kugimiya, F.2
Oshima, Y.3
Ohba, S.4
Ikeda, T.5
Saito, T.6
-
32
-
-
0037198047
-
Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S
-
Nawata H, Yanase T, Goto K, Okabe T, Ashida K. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev 2002; 123: 1101-1106.
-
(2002)
Mech Ageing Dev
, vol.123
, pp. 1101-1106
-
-
Nawata, H.1
Yanase, T.2
Goto, K.3
Okabe, T.4
Ashida, K.5
-
33
-
-
0141614895
-
Effects of dexamethasone on proliferation, differentiation and apoptosis of adult human osteoblasts in vitro
-
Yang L, Tao T, Wang X, Du N, Chen W, Tao S, et al. Effects of dexamethasone on proliferation, differentiation and apoptosis of adult human osteoblasts in vitro. Chin Med J 2003; 116: 1357-1360.
-
(2003)
Chin Med J
, vol.116
, pp. 1357-1360
-
-
Yang, L.1
Tao, T.2
Wang, X.3
Du, N.4
Chen, W.5
Tao, S.6
|